selected publications
-
Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve immunotherapy.
Nature immunology.
2024
Academic Article
GET IT
Times cited: 37 - Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve checkpoint blockade. 2023 GET IT
-
Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer.
Nature communications.
2023
Academic Article
GET IT
Times cited: 28 -
Author Correction: Radiation-activated secretory proteins of Scgb1a1+ club cells increase the efficacy of immune checkpoint blockade in lung cancer.
2022
GET IT
Times cited: 1 -
Radiation-activated secretory proteins of Scgb1a1+ club cells increase the efficacy of immune checkpoint blockade in lung cancer.
Nature cancer.
2021
Academic Article
GET IT
Times cited: 52 -
Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer.
Cell reports.
2020
Academic Article
GET IT
Times cited: 14 -
The lung microenvironment: an important regulator of tumour growth and metastasis.
Nature reviews. Cancer.
2019
Review
GET IT
Times cited: 968 -
Immune reprogramming via PD-1 inhibition enhances early-stage lung cancer survival.
JCI insight.
2018
Academic Article
GET IT
Times cited: 53 -
Fischer et al. reply.
Nature.
2017
Academic Article
GET IT
Times cited: 15 -
Matrix Metalloproteinase 14 promotes lung cancer by cleavage of Heparin-Binding EGF-like Growth Factor.
Neoplasia (New York, N.Y.).
2016
Academic Article
GET IT
Times cited: 51 -
In Vivo Visualization and Characterization of Epithelial-Mesenchymal Transition in Breast Tumors.
Cancer research.
2016
Academic Article
GET IT
Times cited: 71 -
Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1.
Proceedings of the National Academy of Sciences of the United States of America.
2015
Academic Article
GET IT
Times cited: 191 -
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.
Nature.
2015
Academic Article
GET IT
Times cited: 1587 -
Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC.
PloS one.
2015
Academic Article
GET IT
Times cited: 17 -
Transcriptome analysis of individual stromal cell populations identifies stroma-tumor crosstalk in mouse lung cancer model.
Cell reports.
2015
Academic Article
GET IT
Times cited: 148 -
Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition.
Cancer research.
2012
Academic Article
GET IT
Times cited: 256 -
TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer.
Proceedings of the National Academy of Sciences of the United States of America.
2010
Academic Article
GET IT
Times cited: 359 -
Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression.
Biochimica et biophysica acta.
2009
Review
GET IT
Times cited: 169